These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Reflections on the use of PPSB fraction (Prothrombin-proconvertin-Stuart factor-antihemophilic factor B)]. Malinvaud G Transfusion (Paris); 1966; 9(3):245-54. PubMed ID: 5969560 [No Abstract] [Full Text] [Related]
7. The molecular genetics of hemophilia. Lawn RM; Vehar GA Sci Am; 1986 Mar; 254(3):48-54. PubMed ID: 3006240 [No Abstract] [Full Text] [Related]
8. Editorial: Factor VIII inhibitors. Deykin D N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491 [No Abstract] [Full Text] [Related]
9. Molecular biology of coagulation. Pavirani A; Bischoff R Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038 [No Abstract] [Full Text] [Related]
10. Surgery in haemophilic patients with inhibitors. Rodriguez-Merchan EC Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039 [No Abstract] [Full Text] [Related]
11. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction]. Richter K; Klingenberg K; Reinecke D Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427 [No Abstract] [Full Text] [Related]
12. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes]. Baklaja F; Cvetković V; Stajić M; Krivokapić L Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799 [TBL] [Abstract][Full Text] [Related]
13. Activated prothrombin concentrate for patients with factor VIII inhibitors. Kurczynski EM; Penner JA N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485 [No Abstract] [Full Text] [Related]
15. The promise of third-generation recombinant therapy and gene therapy. Manno CS Semin Hematol; 2003 Jul; 40(3 Suppl 3):23-8. PubMed ID: 14690065 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR; Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203 [No Abstract] [Full Text] [Related]
17. Production of recombinant coagulation proteins. Vehar GA Ann N Y Acad Sci; 1987; 509():82-8. PubMed ID: 3122622 [No Abstract] [Full Text] [Related]
18. Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan. Fukutake K Semin Thromb Hemost; 2000; 26(1):29-32. PubMed ID: 10805278 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer as an approach to cure patients with hemophilia A or B. Thompson AR; Palmer TD; Lynch CM; Miller AD Curr Stud Hematol Blood Transfus; 1991; (58):59-62. PubMed ID: 1954775 [No Abstract] [Full Text] [Related]
20. [Substitution therapy with factor 8 and factor IX preparations]. Landbeck G Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465 [No Abstract] [Full Text] [Related] [Next] [New Search]